Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016.

Albaladejo P, Pernod G, Godier A, de Maistre E, Rosencher N, Mas JL, Fontana P, Samama CM, Steib A, Schlumberger S, Marret E, Roullet S, Susen S, Madi-Jebara S, Nguyen P, Schved JF, Bonhomme F, Sié P; members of the French Working Group on Perioperative Haemostasis.

Anaesth Crit Care Pain Med. 2018 May 2. pii: S2352-5568(17)30222-9. doi: 10.1016/j.accpm.2018.04.009. [Epub ahead of print]

2.

Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations: comment.

Marlu R, Jouve T, Polack B, Sié P, Mémier V.

J Thromb Haemost. 2018 May;16(5):1017-1019. doi: 10.1111/jth.13981. Epub 2018 Mar 24. No abstract available.

PMID:
29460346
3.

Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.

Touzé E, Gruel Y, Gouin-Thibault I, De Maistre E, Susen S, Sie P, Derex L.

Eur J Neurol. 2018 May;25(5):747-e52. doi: 10.1111/ene.13582. Epub 2018 Mar 9.

PMID:
29360254
4.

Postauthorization safety study of Clottafact® , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.

Négrier C, Ducloy-Bouthors AS, Piriou V, De Maistre E, Stieltjes N, Borel-Derlon A, Colson P, Picard J, Lambert T, Claeyssens S, Boileau S, Bertrand A, André MH, Fourrier F, Ozier Y, Sié P, Gruel Y, Tellier Z.

Vox Sang. 2018 Feb;113(2):120-127. doi: 10.1111/vox.12624. Epub 2017 Dec 13.

PMID:
29238971
5.

Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.

Gouin-Thibault I, Freyburger G, de Maistre E, Susen S, Delavenne X, Golmard JL, Gruel Y, Sié P; GFHT study group on DOAC.

Thromb Res. 2017 Oct;158:126-133. doi: 10.1016/j.thromres.2017.09.001. Epub 2017 Sep 4.

PMID:
28892657
6.

Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants: An Observational Registry Analysis.

Albaladejo P, Samama CM, Sié P, Kauffmann S, Mémier V, Suchon P, Viallon A, David JS, Gruel Y, Bellamy L, de Maistre E, Romegoux P, Thoret S, Pernod G, Bosson JL; GIHP-NACO Study Group.

Anesthesiology. 2017 Jul;127(1):111-120. doi: 10.1097/ALN.0000000000001631.

PMID:
28410272
7.

Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015.

Albaladejo P, Bonhomme F, Blais N, Collet JP, Faraoni D, Fontana P, Godier A, Llau J, Longrois D, Marret E, Mismetti P, Rosencher N, Roullet S, Samama CM, Schved JF, Sié P, Steib A, Susen S; French Working Group on Perioperative Hemostasis (GIHP).

Anaesth Crit Care Pain Med. 2017 Feb;36(1):73-76. doi: 10.1016/j.accpm.2016.09.002. Epub 2016 Sep 20.

8.

Post-authorization safety study of Clottafact® , a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study.

Négrier C, Rothschild C, Borg JY, Lambert T, Claeyssens S, Sanhes L, Stieltjes N, Bertrand A, André MH, Sié P, Gruel Y, Tellier Z.

Vox Sang. 2016 Nov;111(4):383-390. doi: 10.1111/vox.12424. Epub 2016 Sep 1.

PMID:
27583698
9.

Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.

Sié P.

Drug Des Devel Ther. 2016 May 18;10:1683-9. doi: 10.2147/DDDT.S94167. eCollection 2016. Review.

10.

A diagnostic approach that may help to discriminate inherited thrombocytopenia from chronic immune thrombocytopenia in adult patients.

Fiore M, Pillois X, Lorrain S, Bernard MA, Moore N, Sié P, Viallard JF, Nurden P.

Platelets. 2016 Sep;27(6):555-62. doi: 10.3109/09537104.2016.1143920. Epub 2016 Mar 30.

PMID:
27025585
11.

The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation.

Terrisse AD, Laurent PA, Garcia C, Gratacap MP, Vanhaesebroeck B, Sié P, Payrastre B.

Thromb Haemost. 2016 Jun 2;115(6):1138-46. doi: 10.1160/TH15-08-0661. Epub 2016 Jan 28.

PMID:
26818901
12.

ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1.

Lhermusier T, Severin S, Van Rothem J, Garcia C, Bertrand-Michel J, Le Faouder P, Hechler B, Broccardo C, Couvert P, Chimini G, Sié P, Payrastre B.

J Thromb Haemost. 2016 Mar;14(3):585-95. doi: 10.1111/jth.13247. Epub 2016 Feb 17.

13.

Platelet Adhesion and Thrombus Formation in Whole Blood at Arterial Shear Rate at the End of Pregnancy.

Valéra MC, Parant O, Cenac C, Arnaud C, Gallini A, Hamdi S, Sié P, Arnal JF, Payrastre B.

Am J Reprod Immunol. 2015 Dec;74(6):533-41. doi: 10.1111/aji.12433. Epub 2015 Oct 4.

PMID:
26435170
14.

[Laboratory coagulation tests in patients treated by direct oral anticoagulants (DOACs)].

Sié P.

Presse Med. 2015 Jul-Aug;44(7-8):772-8. doi: 10.1016/j.lpm.2015.06.004. Epub 2015 Aug 3. Review. French.

PMID:
26248706
15.

Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.

Nurden AT, Pillois X, Fiore M, Alessi MC, Bonduel M, Dreyfus M, Goudemand J, Gruel Y, Benabdallah-Guerida S, Latger-Cannard V, Négrier C, Nugent D, Oiron RD, Rand ML, Sié P, Trossaert M, Alberio L, Martins N, Sirvain-Trukniewicz P, Couloux A, Canault M, Fronthroth JP, Fretigny M, Nurden P, Heilig R, Vinciguerra C.

Hum Mutat. 2015 May;36(5):548-61. doi: 10.1002/humu.22776.

16.

Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions.

Levade M, David E, Garcia C, Laurent PA, Cadot S, Michallet AS, Bordet JC, Tam C, Sié P, Ysebaert L, Payrastre B.

Blood. 2014 Dec 18;124(26):3991-5. doi: 10.1182/blood-2014-06-583294. Epub 2014 Oct 10.

17.

Platelet activation and arterial peripheral serotonin turnover in cardiac remodeling associated to aortic stenosis.

Rouzaud-Laborde C, Delmas C, Pizzinat N, Tortosa F, Garcia C, Mialet-Perez J, Payrastre B, Sié P, Spreux-Varoquaux O, Sallerin B, Carrié D, Galinier M, Parini A, Lairez O.

Am J Hematol. 2015 Jan;90(1):15-9. doi: 10.1002/ajh.23855.

18.

Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.

Lhermusier T, Voisin S, Murat G, Mejean S, Garcia C, Bataille V, Lipinski MJ, Carrié D, Sié P.

Int J Cardiol. 2014 Jul 1;174(3):874-6. doi: 10.1016/j.ijcard.2014.04.208. Epub 2014 Apr 26. No abstract available.

PMID:
24820749
19.

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.

Noris P, Schlegel N, Klersy C, Heller PG, Civaschi E, Pujol-Moix N, Fabris F, Favier R, Gresele P, Latger-Cannard V, Cuker A, Nurden P, Greinacher A, Cattaneo M, De Candia E, Pecci A, Hurtaud-Roux MF, Glembotsky AC, Muñiz-Diaz E, Randi ML, Trillot N, Bury L, Lecompte T, Marconi C, Savoia A, Balduini CL, Bayart S, Bauters A, Benabdallah-Guedira S, Boehlen F, Borg JY, Bottega R, Bussel J, De Rocco D, de Maistre E, Faleschini M, Falcinelli E, Ferrari S, Ferster A, Fierro T, Fleury D, Fontana P, James C, Lanza F, Le Cam Duchez V, Loffredo G, Magini P, Martin-Coignard D, Menard F, Mercier S, Mezzasoma A, Minuz P, Nichele I, Notarangelo LD, Pippucci T, Podda GM, Pouymayou C, Rigouzzo A, Royer B, Sie P, Siguret V, Trichet C, Tucci A, Saposnik B, Veneri D; European Hematology Association – Scientific Working Group on Thrombocytopenias and Platelet Function Disorders.

Haematologica. 2014 Aug;99(8):1387-94. doi: 10.3324/haematol.2014.105924. Epub 2014 Apr 24.

20.

[Perioperative management of new oral anticoagulants].

Samama CM, Pernod G, Albaladejo P, Sie P; Groupe d’intérêt en hémostase péri-opératoire (GIHP).

Presse Med. 2014 Jun;43(6 Pt 1):637-44. doi: 10.1016/j.lpm.2013.11.025. Epub 2014 Apr 16. Review. French.

PMID:
24742616
21.

[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013].

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P.

Ann Fr Anesth Reanim. 2013 Oct;32(10):691-700. doi: 10.1016/j.annfar.2013.04.016. Epub 2013 Aug 30. Review. French. Erratum in: Ann Fr Anesth Reanim. 2014 Mar;33(3):198-9.

PMID:
23993157
22.

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P; Working Group on Perioperative Haemostasis.

Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):382-93. doi: 10.1016/j.acvd.2013.04.009. Epub 2013 Jun 25.

23.

[Questions--answers on the use of rivaroxaban for the treatment of venous thromboembolic disease].

Pernod G, Elias A, Gouin I, Gaillard C, Nguyen P, Ouvry P, Sié P.

J Mal Vasc. 2012 Dec;37(6):300-10. doi: 10.1016/j.jmv.2012.09.003. Epub 2012 Nov 2. French.

PMID:
23122646
24.

Large psoas haematoma and femoral neuropathy in a patient with type 2B von Willebrand's disease.

Pailhes R, Lafosse JM, Marty P, Dahan O, Voisin S, Sié P.

Haemophilia. 2012 Nov;18(6):e407-8. doi: 10.1111/hae.12022. Epub 2012 Sep 25. No abstract available.

PMID:
23005922
25.

Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α.

Valéra MC, Gratacap MP, Gourdy P, Lenfant F, Cabou C, Toutain CE, Marcellin M, Saint Laurent N, Sié P, Sixou M, Arnal JF, Payrastre B.

Blood. 2012 Aug 23;120(8):1703-12. doi: 10.1182/blood-2012-01-405498. Epub 2012 Jul 9.

26.

Switching patients from clopidogrel to prasugrel in acute coronary syndrome: effects of prasugrel loading dose on residual platelet reactivity.

Lhermusier T, Voisin S, Mejean S, Garcia C, Sié P, Carrié D.

J Thromb Haemost. 2012 Sep;10(9):1946-9. doi: 10.1111/j.1538-7836.2012.04838.x. No abstract available.

27.

Inherited platelet disorders and oral health.

Valera MC, Kemoun P, Cousty S, Sie P, Payrastre B.

J Oral Pathol Med. 2013 Feb;42(2):115-24. doi: 10.1111/j.1600-0714.2012.01151.x. Epub 2012 May 15. Review.

PMID:
22583386
28.

[Renal biopsy practice: results of a French study and recommendations].

Bollée G, Moulin B, Martinez F, Meulders Q, Rougier JP, Baumelou A, Glotz D, Subra JF, Ulinski T, Vrigneaud L, Brasseur J, Alhenc-Gelas M, Martin L, Daniel L, Kourilsky O, Deteix P, Sie P, Ronco P, Houillier P; Groupe de travail de la Société de Néphrologie.

Nephrol Ther. 2012 Jun;8(3):168-76. doi: 10.1016/j.nephro.2011.12.005. Epub 2012 Mar 16. French.

PMID:
22425459
29.

Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis.

Sié P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, Van der Linden P, Pernod G, Lecompte T, Gouin-Thibault I, Albaladejo P; Working Group on Perioperative Haemostasis; French Study Group on Thrombosis and Haemostasis.

Arch Cardiovasc Dis. 2011 Dec;104(12):669-76. doi: 10.1016/j.acvd.2011.09.001. Epub 2011 Oct 29.

30.

The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.

Lhermusier T, van Rottem J, Garcia C, Xuereb JM, Ragab A, Martin V, Gratacap MP, Sié P, Payrastre B.

J Thromb Haemost. 2011 Oct;9(10):2067-76. doi: 10.1111/j.1538-7836.2011.04470.x.

31.

[Surgery and invasive procedures in patients on long-term treatment with oral direct thrombin or factor Xa inhibitors].

Sié P, Samama CM, Godier A, Rosencher N, Steib A, Llau JV, van der Linden P, Pernod G, Lecompte T, Gouin-Thibault I, Albaladejo P.

Ann Fr Anesth Reanim. 2011 Sep;30(9):645-50. doi: 10.1016/j.annfar.2011.06.018. Epub 2011 Aug 5. Review. French.

PMID:
21820844
32.

Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels.

Voisin S, Bongard V, Tidjane MA, Lhermusier T, Carrié D, Sié P.

Thromb Haemost. 2011 Aug;106(2):227-9. doi: 10.1160/TH11-01-0046. Epub 2011 May 5.

PMID:
21544318
33.

Short-term effects of the smoke-free legislation on haemostasis and systemic inflammation due to second hand smoke exposure. The AERER study.

Cayla G, Sié P, Silvain J, Brugier D, Cambou JP, Thomas D, Pena A, O'Connor SA, Bura A, Ruidavets JB, Montalescot G, Collet JP.

Thromb Haemost. 2011 Jun;105(6):1024-31. doi: 10.1160/TH11-02-0062. Epub 2011 Apr 20.

PMID:
21505721
34.

More on: adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.

Tidjane MA, Voisin S, Lhermusier T, Bongard V, Sié P, Carrié D.

J Thromb Haemost. 2011 Mar;9(3):614-6. doi: 10.1111/j.1538-7836.2010.04180.x. No abstract available.

35.

Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow.

Terrisse AD, Puech N, Allart S, Gourdy P, Xuereb JM, Payrastre B, Sié P.

J Thromb Haemost. 2010 Dec;8(12):2810-9. doi: 10.1111/j.1538-7836.2010.04088.x.

36.

French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).

Pernod G, Godiér A, Gozalo C, Tremey B, Sié P; French National Authority for Health.

Thromb Res. 2010 Sep;126(3):e167-74. doi: 10.1016/j.thromres.2010.06.017. Epub 2010 Jul 14. Review.

PMID:
20630568
37.

Renal biopsy practice in France: results of a nationwide study.

Bollée G, Martinez F, Moulin B, Meulders Q, Rougier JP, Baumelou A, Glotz D, Subra JF, Ulinski T, Vrigneaud L, Brasseur J, Martin L, Daniel L, Kourilsky O, Deteix P, Sie P, Ronco P, Houillier P.

Nephrol Dial Transplant. 2010 Nov;25(11):3579-85. doi: 10.1093/ndt/gfq254. Epub 2010 May 11.

PMID:
20466684
38.

The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo.

Gratacap MP, Martin V, Valéra MC, Allart S, Garcia C, Sié P, Recher C, Payrastre B.

Blood. 2009 Aug 27;114(9):1884-92. doi: 10.1182/blood-2009-02-205328. Epub 2009 Jun 3.

39.

Association of neutrophil count with microembolization in patients with symptomatic carotid artery stenosis.

Nasr N, Ruidavets JB, Arnal JF, Sie P, Larrue V.

Atherosclerosis. 2009 Dec;207(2):519-23. doi: 10.1016/j.atherosclerosis.2009.05.003. Epub 2009 May 13.

PMID:
19486978
40.

Assessment of platelet response to clopidogrel through measurement of ADP-induced Akt phosphorylation.

Carrié D, Garcia C, Gratacap MP, Voisin S, Payrastre B, Sié P.

J Thromb Haemost. 2009 Aug;7(8):1411-3. doi: 10.1111/j.1538-7836.2009.03485.x. Epub 2009 May 15. No abstract available.

41.
42.

Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis.

Arnal JF, Douin-Echinard V, Tremollières F, Terrisse AD, Sié P, Payrastre B, Guery JC, Bayard F, Gourdy P.

Arch Mal Coeur Vaiss. 2007 Jun-Jul;100(6-7):554-62. Review.

PMID:
17893638
43.

Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.

Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC.

Thromb Haemost. 2007 Jun;97(6):949-54.

PMID:
17549297
44.

[Reference center for platelet diseases].

Nurden P, Dreyfus M, Favier R, Négrier C, Schlégel N, Sie P, Nurden A.

Arch Pediatr. 2007 Jun;14(6):679-82. Epub 2007 Apr 6. French. No abstract available.

PMID:
17419014
45.

Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.

Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc JL, Bagheri H.

Eur J Clin Pharmacol. 2007 Mar;63(3):221-8. Epub 2007 Jan 17.

PMID:
17225990
46.

Central laboratory and point of care assessment of perioperative hemostasis.

Sié P, Steib A.

Can J Anaesth. 2006 Jun;53(6 Suppl):S12-20. Review.

PMID:
16766785
47.
48.

Microparticles from apoptotic vascular smooth muscle cells induce endothelial dysfunction, a phenomenon prevented by beta3-integrin antagonists.

Essayagh S, Brisset AC, Terrisse AD, Dupouy D, Tellier L, Navarro C, Arnal JF, Sié P.

Thromb Haemost. 2005 Oct;94(4):853-8.

PMID:
16270642
49.

Integrin-dependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets.

Bodin S, Soulet C, Tronchère H, Sié P, Gachet C, Plantavid M, Payrastre B.

J Cell Sci. 2005 Feb 15;118(Pt 4):759-69. Epub 2005 Jan 25.

50.

Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?

Giansily-Blaizot M, Verdier R, Biron-Adréani C, Schved JF, Bertrand MA, Borg JY, Le Cam-Duchez V, Briquel ME, Chambost H, Pouymayou K, Dutrillaux F, Favier R, Martin-Toutain I, Verdy E, Gay V, Goudemand J, Navarro R, Durin A, d'Oiron R, Lambert T, Pernod G, Barrot C, Peynet J, Bastenaire B, Sie P, Stieltjes N, Torchet MF, de Moerloose P; Study group of FVII deficiency.

Haematologica. 2004 Jun;89(6):704-9. Erratum in: Haematologica. 2007 Nov;92(11):1584. LeCam-Duchez, V [corrected to Le Cam-Duchez, V].

Supplemental Content

Support Center